Journal of Clinical Lipidology

Article	Citations
Cholesterol screening and intervention in youth - It's time to move on	81
From the Editors: More Hot Topics in Clinical Lipidology	74
A New Epoch in Treating Diseases of the Heart	66
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy	42
Impact of Cumulative Exposure to a High TG to HDL-C Ratio on Type 2 Diabetes Risk in Young Adults	40
Novel 327bp Alu element insertion in LDLR exon 17 causes alternative splicing and familial hypercholesterolemia	39
Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly-diagnosed metastatic pancreatic adenocarcinoma	36
Utilizing innovative implementation strategies for familial hypercholesterolemia: Correspondence	36
From the editor: Hope and strength in community	32
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes	30
From the editor: A compendium of lipidology progress	30
Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit	30
Mysterious Case of Reduction in HDL Cholesterol in a Patient with B-cell Monocytosis	26
JCL Roundtable. The lipidology team	26
Genetic Architecture and Cardiovascular Risk of Familial Combined Hyperlipidemia	25
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine	23
*A Novel ABCG8 Variant and Apo(A) Short Isoform Associated with Premature Atherosclerosis and Familial Hypercholesterolemia Phenocopy.	23
^Sex Disparities in the Treatment and Outcomes of Familial Hypercholesterolemia	22
†Efficacy and Safety of Bempedoic Acid in Patients with Metabolic Syndrome	22
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database	21
†Does Cholesterol Screening in Prader Willi Syndrome Represent an Opportunity to Reduce Cardiovascular Disease Risk?	20
Association Between Dietary Fat Content and Serum Lipoprotein(a) Level	19
Racial Difference in Hypertriglyceridemia and Its Impact on Coronary Heart Diseases	19
The NLRP3 inhibitor and Nrf2 Agonist, RRx-001, Ameliorates Non-alcoholic Fatty Liver Disease in Rats	17
The Effect of Estrogen and Testosterone on Cholesterol Crystallization	17

Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse	16
† Higher Cardiovascular Event Rates for High-Risk Americans Who Did Not Meet 2018 Multidisciplinary Guideline on the Management of Blood Cholesterol Thresholds	15
† The Vast Majority of High- and Very-High Risk Hypercholesterolemia Patients Never Reach below LDL-C Thresholds in the 2018 ACC/AHA Guidelines	15
Effect of Dexamethasone on Modulating Lp(a) Levels in COVID-19 Pneumonia	15
Treatment Target Achievement in Patients with Familial Hypercholesterolemia: A Real-World Descriptive Study	15
† Survival into the Eleventh Decade in Persons Receiving Statin Therapy	14
Familial LCAT (Lecithin: Cholesterol Acyltransferase) Deficiency: A Case Report	14
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease	14
Patients with Dyslipidemia and Heart Failure Affected by Non-Alcoholic Fatty Liver Disease Have higher Mortality and Worse Clinical Outcomes, Nation-Wide Study	14
† Investigating Hepatocyte Cholesterol Uptake Ex Vivo Following CSL112 (Apolipoprotein A-I [Human]) Infusion in Post Myocardial Infarction Patients	13
Usefulness of the ApoB Quick Diagnosis App in the Diagnosis of Suspected Familial Chylomicronemia Syndrome	13
Atrial Fibrillation Outcome in Patients with Familiar Hypercholesterolemia	13
The Outcome of Percutaneous Coronary Intervention in Patients with Familial Hypercholesterolemia: A Nationwide Analysis	13
Using Virtual Reality and Other Immersive Tools to increase HCPs Ability to Differentially Diagnose and Manage FH	12
Genetic Variants in Patients with Persistent, Severe Hypertriglyceridemia	12
LP-PLA2 is more Effective at Predicting Elevated CV Risk in Law Enforcement Officers as Compared to Framingham Risk or Coronary Calcium Scoring	12
Medications Are Not Enough: Interdisciplinary Treatment of Familial Chylomicronemia Syndrome in Pregnancy	12
Patients with Familial Hypercholesterolemia with Non-Alcoholic Fatty Liver Disease Have Worse Clinical Outcomes, Nation-Wide Study	12
Evinacumab Markedly Reduces Low-density Lipoprotein Cholesterol in Adolescent Patients With Homozygous Familial Hypercholesterolemia†	11
Long-Term Efficacy and Safety of Twice-Yearly Inclisiran in Patients with ASCVD and Elevated LDL-C: A Post-Hoc Analysis of ORION-3, a 4-year Open-Label Extension Study	11
Clinical and Economic Impact of Early Rreatment Initiation with Evolocumab in Patients with a Recent Myocardial Infarction in the United States	11
Moderate Alcohol Consumption and Lipoprotein Subfractions: A Systematic Review of Intervention and Observational Studies	11
† Triglyceride Patterns among Patients in US Clinical Practice	11
News from NLA- Jan-Feb 2022	10
Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis	10
Egg consumption induces changes in clinical leukocyte markers that are dependent on sex and baseline white blood cell counts	10
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice	10
Editorial Board	10
JCL Roundtable: Global Think Tank on Lipoprotein(a)	10
Carotid sheath xanthoma: A rare manifestation of lipid disorders	10
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss	10
Hypertriglyceridemia is associated with better outcomes in patients hospitalized for ischemic stroke.	10
Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived	10
Eicosapentaenoic acid Reduces Expression of Pulmonary Endothelial Angiotensin Converting Enzyme (ACE) Linked to Inflammation	9
Treatment Gap in Prevention of Myocardial Infarction in Rural New York State	9
A Single-Dose, Four-way-Crossover Comparative Bioavailability Study of Two Omega-3 Formulations under Fasting and Fed Conditions in Healthy Volunteers	9
Direct LDL-C estimation in preschoolers: Practicable first step for FH screening	9
Statin therapy for primary prevention in men: What is the role for coronary artery calcium?	8
The Dyslipidemia Paradox in Patients Hospitalized for Heart Failure	8
Challenges and opportunities for identifying people with Familial hypercholesterolaemia in the UK: Evidence from the National FH PASS database	8
A stepwise approach to prescribing novel lipid-lowering medications	8
Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans	8
Editorial Board	8
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013–2020	8
Genomic study of maternal lipid traits in early pregnancy concurs with four known adult lipid loci	8
Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at Canadian quaternary care hospitals	8
Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort	8
From the editor: Trust and the value paradox in science	8
Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors	8
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia	7

In memoriam, Avedis Khachadurian 1926 - Sept 22,2022	7
From the Editors: Inhibition of cholesteryl ester transfer protein (CETP): Still a promising therapeutic strategy?	7
Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System	7
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis	7
Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease	7
Editorial Board	7
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis	7
ASCVD Risk Stratification in a Large Urban Clinic – Role of CACS in Reclassifying Black versus White Individuals Seen for Preventive Care.	7
Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy	7
Monocyte/lymphocyte ratio as a risk factor of cardiovascular and all-cause mortality in coronary artery disease with low-density lipoprotein cholesterol levels below 1.4 mmol/L: A large longitudinal m	7
Management of diabetic dyslipidemia in South Asian patients: The need for individualized treatment guidelines.	7
News from NLA	7
Clinical Outcomes And Mortality in Heart Failure And Chronic Kidney Disease Patients Admitted With Non-Variceal Upper Gastrointestinal Bleeding	7
Comparison of Package Insert versus Real World Safety Data from Branded Icosapent Ethyl Users: A Select Analysis Utilizing MarketScan Data	7
†Role of Epigenetic Regulation and Sp1 Rranscription Factor on DP1 Receptor Expression in Osteoarthritis	6
†The Role of Structured Inpatient Lipid Protocols in Optimizing Non-Statin Lipid Lowering Therapy: A Review and Single-Center Experience	6
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19	6
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance	6
The Food Compass Score is Negatively Related to the Activity of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Healthy Adults.	6
A Controlled Intervention Restricting AGEs Improves Carboxymethyl Lysine, RAGE, Lipid, and Inflammatory Indices in Patients Undergoing Hemodialysis	6
+Racial Inequities in Coronary Artery Calcium Screening and Follow-up	6
Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation	6
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience	6
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results	6
Negative LDL-C levels with Detectable Apolipoprotein B: Surrogate Markers of Atherosclerotic Disease and Cardiac Event Risk	6
†Assessment of Unmet Clinical Needs and Healthcare Resource Use among Statin-Treated Patients with or at Risk of Developing ASCVD	6
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome	6
Substantially elevated TSH, not traditional clinical subclinical thyroid disorder groupings, are associated with smaller LDL-P mean size: ELSA-Brasil	6
A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels	5
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study	5
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia	5
Disparities in access to pharmacotherapies for weight loss and cardiovascular prevention	5
The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States	5
HDL proteome remodeling associates with COVID-19 severity	5
Characteristics and trends of PCSK9 inhibitor prescription fills in the United States	5
Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic	5
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects	5
Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease	5
High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population	5
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection	4
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial	4
Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2	4
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?	4
Ezetimibe in the management of homozygous familial hypercholesterolaemia	4
Closing the gap: Identification and management of familial hypercholesterolemia in an integrated healthcare delivery system	4
Niacin and clinical utility, don't be misled by recent niacin metabolite report	4
Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice	4
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association	4
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial	4
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia	4
Lipoprotein(a) and High-Density Lipoprotein – A Tale of Two Cities?	4
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis	4
Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease	4
Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)	4
High-density lipoprotein infusion therapy: A review	4
Genetic variants in triglyceride metabolism genes among individuals with hypertriglyceridemia in Colombia	4
Rapid lipid-lowering response in two cases of autosomal recessive hypercholesterolemia	4
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States	4
Lipidomic changes of LDL after consumption of Camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism—A randomized controlled trial	4
Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study	4
Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial” [Journal of Clinical Lipid	4
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia	4
The impact of dyslipidemia on early markers of endothelial and renal dysfunction in children	4
Real-world utilization of bempedoic acid in an academic preventive cardiology practice	4
High-intensity statins vs. moderate-intensity statin-ezetimibe combination therapy: A patient centered approach	4
Malar rash and hand tremor in early symptoms of cerebrotendinous xanthomatosis and the effect of chenodeoxycholic acid on them	4
Different Manifestations of Familial Hypercholesterolemia in a Mother and Daughter Due to Differing Lipoprotein(a) Levels	4
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table	4
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association	4
CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis	4
News from NLA December 2021	3
Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort	3
Pathogenic Intron Variant Familial Hypercholesterolemia: An Atypical Presentation	3
Statin prescribing for primary prevention among people living with HIV	3
Serum 25-hydroxycholesterol levels are increased in patients with coronavirus disease 2019	3
Impact of conducting a genetic study on the management of familial hypercholesterolemia	3
Impact of Non-Alcoholic Fatty Liver Disease on Heart Failure Hospitalizations: Insights from the National Inpatient Sample Database	3
*Real-World Experience with Inclisiran at a Large Academic Lipid Clinic	3
Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia – Analysis of Secondary and Safety Endpoints from the APH-19 Study	3
Clinical Outcomes in Patients admitted with Diabetes Mellitus and Chronic Kidney Disease Affected by Non-Alcoholic Fatty Liver Disease	3

Sex‐related differences in premature cardiovascular disease in familial hypercholesterolemia	3
Associations of HDL subclasses and lipid content with complement proteins over the menopause transition: The SWAN HDL ancillary study	3
Evidence regarding SGLT2 inhibitors for the management of diabetic dyslipidemia	3
JCL roundtable: Evolution of preventive cardiology and clinical lipidology	3
Use of lipid-lowering therapies in patients with CKD and ASCVD: A 1-year update from GOULD	3
Development of the Family Heart Foundation™ Flag, Identify, Network, Deliver—Familial Hypercholesterolemia (FIND-FH™) Implementation Toolkit	3
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results	3
+Differences in Clinical Outcomes between Non-Obese Caucasian and Hispanic Populations Who have Hyperlipidemia	3
Detailed Family History of Premature Atherosclerotic Cardiovascular Disease to Guide Lipoprotein(a) Testing: The Multi-Ethnic Study of Atherosclerosis	3
A Rare Encounter: Familial Lipoprotein Lipase Deficiency in Pregnancy - Case Review and Emerging Therapies for Familial Chylomicronemia Syndrome	3
Novel APOB mutation in familial hypobetalipoproteinemia	3
Editorial Board	3
From the editor: Competition and community	3
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study	3
Letter regarding the article Sex-Related Differences in Premature Cardiovascular Disease in Familial Hypercholesterolemia	3
Statin therapy upregulated arachidonic acid status via enhanced endogenous synthesis in patients with plaque psoriasis	3
Population Analysis of Patients at a Multidisciplinary Prevention Center: Insights, Gaps, and Opportunities	3
Lipid lowering Injectable Clinic-Novel Idea for Improving Compliance with Twice Yearly Dosing of Inclisiran	3
Oleocanthal-Rich Olive Oil's Effect on Postprandial Platelet Activity and Oxidative Stress Markers of Type 2 Diabetic Patients	3
†High Rates of Cardiovascular Events in Patients with Multivessel Disease in the First Year Post-Myocardial Infarction: A Systematic Literature Review	3
Editorial Board	2
From the Editors: Familial hypercholesterolemia: Still underdiagnosed and undertreated	2
Recurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study	2
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV	2
Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes	2
Lipid Biomarkers Associated with Mortality in COVID-19	2
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten	2
A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease	2
First clinical experiences with inclisiran in a real-world setting	2
Cholesterol trajectories and its relationship with viral load in HIV patients over time	2
Transcatheter aortic valve replacement in a patient with premature coronary artery disease and calcific aortic stenosis complicated by heterozygous familial hypercholesterolemia	2
Editorial Board	2
Racial Variations in SGLT2 Inhibitor Prescriptions	2
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors: identification of a new class of small molecules	2
*Achievement of Low-Density Lipoprotein Cholesterol (LDL-C) Thresholds in Patients with Very High-Risk Atherosclerotic Cardiovascular Disease (ASCVD)	2
Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice	2
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association	2
JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk	2
Identification of High Cardiovascular Disease Risk Individuals in an Underserved Patient Population Clinic	2
Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia	2
Characteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17-year period	2
Association of demographic and health characteristics with circulating oxysterol concentrations	2
Association between changes in high-density lipoprotein cholesterol and risk of cardiovascular disease	2
Table of Contents	2
The recognition and appreciation of Familial Hypercholesterolemia among Internal Medicine residents in the United States	2
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)	2
†Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-human Primates	2
Editorial Board	2
Table of Contents	2
Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols	2
The Relationship of Alcohol Consumption and HDL Metabolism in the Multiethnic Dallas Heart Study	2
A case of lipoprotein glomerulopathy due to the pathogenic APOE Las Vegas variant c.509C>A: p. (Ala170Asp)	2
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI	2
Possible explanations for the common clinical familial hypercholesterolemia phenotypes in the Faroe Islands	2
Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia	2
News from the NLA	2
News from NLA_May/June 2022	2
Table of Contents	2
Table of Contents	2
Successful pregnancy outcome in a woman with cholesteryl ester storage disease treated with enzyme replacement therapy	1
Lipid-lowering efficacy of obicetrapib: A comprehensive systematic review and meta-analysis.	1
Exploring rates of PCSK9 inhibitor persistence and reasons for treatment non-persistence in an integrated specialty pharmacy model	1
Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic	1
Patient-Centered Themes in Adults with Very High Levels of LDL Cholesterol Expressed During Therapeutic Songwriting	1
†Safety and Efficacy of Bempedoic Acid in Patients with Renal Impairment	1
Case report: 68 yo Chinese-American woman with high HDL-C and ischemic stroke attributed to intracranial atherosclerotic stenosis	1
† Pharmacokinetics of Mibavademab in Healthy Participants: Results from a Randomized, Phase 1, Two-Part, First-in-Human Study	1
Lifestyle Intervention in Primary Care Patients with Metabolic Syndrome	1
Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease	1
Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania Health System	1
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia	1
Non-High-Density Lipoprotein Cholesterol Outperforms Low-Density Lipoprotein Cholesterol in Predicting Cardiovascular Events Among High-Risk Asians	1
The therapeutic effect of liver transplantation in 14 children with homozygous familial hypercholesterolemia: a prospective cohort	1
Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)	1
The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway	1
Editorial Board	1
Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: The ELSA-Brasil study	1
Association between Niacin ER Use, Safety, and Cardiovascular Events: A Single Center Experience	1
Characteristics of Patients Initiating Inclisiran in the Real World: A Retrospective Analysis of a US Database	1
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research	1
Eicosapentaenoic Acid Reverses Endothelial Dysfunction following Exposure to the Cytokine IL-6 in Contrast to Docosahexaenoic and Arachidonic Acids	1
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment	1
Pregnancy-Induced Hypertension: The Potential Role of Cholesterol Crystals in the Maternal Decidua	1
Identification and functional analysis of novel homozygous LMF1 variants in severe hypertriglyceridemia	1
Effects of Predominantly African American CYP3A Polymorphisms on Statin Intolerance	1
Remnant cholesterol and risk of myocardial infarction in patients with coronary artery disease undergoing revascularization	1
The effect of evinacumab on LDL-C goal attainment in patients with homozygous familial hypercholesterolemia	1
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey	1
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use	1
From the editor: Prevention then and now	1
The Prediction and Prevention of Diabetes Mellitus	1
† A Randomized Study to Compare LDL-C-Lowering Effects of Inclisiran with Usual Care vs Usual Care Alone in Patients with Recent Hospitalization for an Acute Coronary Syndrome: Rationale and Design of	1
News from NLA	1
Patients with raised Lipoprotein(a) are committed to being involved in clinical trials to develop a treatment to lower Lp(a): results of a survey distributed via the Lipoprotein(a) Foundation.	1
Impact of small dense low-density lipoprotein cholesterol on cholesterol crystals in patients with acute coronary syndrome: An optical coherence tomography study	1